3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
43
Breast Neoplasms
30
Lymphoma
28
Sarcoma
26
Hodgkin Disease
24
Triple Negative Breast Neoplasms
20
Burkitt Lymphoma
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Follicular
16
Neoplasms
15
Ovarian Neoplasms
14
Lymphoma, Non-Hodgkin
13
Lymphoma, B-Cell
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, T-Cell, Peripheral
9
Endometrial Neoplasms
9
Neuroblastoma
7
Neoplasm Metastasis
7
Lymphoma, Mantle-Cell
7
Liposarcoma
7
Leukemia
7
Fallopian Tube Neoplasms
7
Recurrence
6
Multiple Myeloma
6
Leiomyosarcoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Inflammatory Breast Neoplasms
5
Histiocytoma, Malignant Fibrous
5
Interventions
Cyclophosphamide
7
fludarabine phosphate
5
fludarabine
4
Whole-Body Irradiation
4
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
ibrutinib
3
Mycophenolic Acid
3
Mesna
3
Busulfan
3
pirtobrutinib
2
Patient Reported Outcome Measures
2
Melphalan
2
Bone Marrow Transplantation
2
Biopsy
2
venetoclax
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
duvelisib
1
Thiotepa
1
Surveys and Questionnaires
1
Social Determinants of Health
1
Sirolimus
1
Receptors, Chimeric Antigen
1
Methotrexate
1
Leukapheresis
1
Immunotherapy, Adoptive
1
Cyclosporins
1
Cyclosporine
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphoid
×
Doxorubicin
×
1 year
×
Clear all
No trials found.